Article
IgM Plasma Cell Myeloma.
American journal of clinical pathology - 6 Jan 2022
Lu Haiyan, Durkin Lisa, Zhao Xiaoxian, Nakashima Megan O
Abstract excerpt
OBJECTIVES: Immunoglobulin M plasma cell myeloma (IgMPCM) is a rare entity that is difficult to distinguish from other IgM-related neoplasms. The study aims to characterize the clinicopathologic features of IgMPCM, including MYD88 L265P and CXCR4 mutations. METHODS: From our institutional archives, bone marrow biopsy specimens from January 1, 2008, to December 1, 2018, with monotypic plasma cells (PCs) expressing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
